Viewing Study NCT06658834

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:30 AM
Ignite Modification Date: 2026-01-24 @ 5:44 AM
Study NCT ID: NCT06658834
Status: RECRUITING
Last Update Posted: 2024-10-26
First Post: 2024-09-19
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of Romiplostim N01 as the First-line Treatment for Newly Diagnosed Adult Patients With ITP
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Primary Immune Thrombocytopenia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ITP View
None Romiplostim View
None Continuous Remission View